Position in IBRX
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$120,722
-$46,000 QoQ
Shares Held
13,789
-36.6% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#271
of 401 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in IBRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Capital Investment Advisors, LLC holds $3,193,049 across 6 Biotechnology names. IBRX ranks #5 (3.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INSM |
INSMED Inc
|
13,238 | $1,411,435 | |
| 2 | AUPH |
Aurinia Pharmaceuticals Inc.
|
39,055 | $662,763 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,207 | $599,553 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
530 | $330,476 | |
| 5 | IBRX |
ImmunityBio, Inc.
This page
|
13,789 | $120,722 | |
| 6 | TSHA |
Taysha Gene Therapies, Inc.
|
10,000 | $68,100 |
All Filings in IBRX
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $120,722 | 13,789 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $166,722 | 21,737 | Shares | Sole | 2026-04-17 | |
| No filing history on record for this holder in this stock. | ||||||